Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reata Pharma (NQ: RETA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 172.36 (11) Ask (Size) 172.50 (475) Prev. Close 172.36 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 36,948,063 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Via Benzinga An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8 October 05, 2023 Paying Attention To Gold Miners On Zero Hedge on Monday, contributing editor “Quoth The Raven” suggested “paying urgent attention to gold miners”: Via Benzinga Performance More News Read More Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Shareholder Notice: Investigation over Potential Wrongdoing October 04, 2023 Via SBWire Biogen Completes Acquisition of Reata Pharmaceuticals September 26, 2023 From Biogen Inc. Via GlobeNewswire Analyst Ratings for Reata Pharmaceuticals August 15, 2023 Via Benzinga Reata Pharmaceuticals Inc. (NASDAQ: RETA) Climbs to New 52-Week High September 21, 2023 Via Investor Brand Network Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc. September 21, 2023 From Reata Pharmaceuticals, Inc. Via Business Wire Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy? September 09, 2023 Via The Motley Fool 7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth September 07, 2023 Via InvestorPlace The 7 Most Promising Momentum Stocks to Own Now August 31, 2023 Via InvestorPlace The 3 Most Promising Pharma Stocks to Own Now August 30, 2023 Via InvestorPlace REATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA August 28, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone Energy, Inc. (NYSE - ESTE), Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), Reata Pharmaceuticals, Inc. (Nasdaq - RETA) August 21, 2023 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA) August 17, 2023 From Brodsky & Smith LLC Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session August 14, 2023 Via Benzinga With an Acquisition on the Way, Is Biogen Stock a Buy? August 09, 2023 Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED) August 08, 2023 From Brodsky & Smith LLC Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session August 08, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA) August 07, 2023 From Brodsky & Smith LLC Via GlobeNewswire REATA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA August 02, 2023 From Kahn Swick & Foti, LLC Via Business Wire Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points August 01, 2023 Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 August 01, 2023 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX) August 01, 2023 From Brodsky & Smith LLC Via GlobeNewswire Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know. August 01, 2023 Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023 July 31, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.